Friedman, D. R., Stewart, T., Guadalupe, E., Brander, D. M., Pisetsky, D. S., & Weinberg, J. B. (2015). Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism. In Journal of Clinical Oncology (Vol. 33, pp. e13536–e13536). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.e13536

Friedman, Daphne Ruth, Tiffany Stewart, Eross Guadalupe, Danielle M. Brander, David S. Pisetsky, and J Brice Weinberg. “Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism.” In Journal of Clinical Oncology, 33:e13536–e13536. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.e13536.

Friedman DR, Stewart T, Guadalupe E, Brander DM, Pisetsky DS, Weinberg JB. Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e13536–e13536.

Friedman, Daphne Ruth, et al. “Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. e13536–e13536. Crossref, doi:10.1200/jco.2015.33.15_suppl.e13536.

Friedman DR, Stewart T, Guadalupe E, Brander DM, Pisetsky DS, Weinberg JB. Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e13536–e13536.